'김갑성' 기자의 전체기사
-
SO TECHAFRICA and Mindhyve.ai™ Forge Strategic Alliance to Ad…
ABUJA, Nigeria and NEWPORT BEACH, Calif., July 31, 2025 -- In a landmark collaboration aimed at accelerating innovation, capacity building, and digital transformation across Nigeria, SO TECHAFRICA LTD and U.S.-based Mindhyve.ai™ have signed a Memorandum of Understanding (MoU) to deploy agentic artificial intelligence (AI) in critical development sectors including education, healthcare, and public sector transformation. This forward-looking alliance will pioneer real-world applications of Mindhyve.ai's cutting-edge agentic AI systems—beginning with ArthurAI (focused on e
- 김갑성 기자
- 2025-07-31 06:01
-
Journey、Starlabと提携し商業宇宙ステーションの体験デザインを手がける
ヒューストン, 2025年7月31日 -- Starlab Space LLC は、次世代型商業宇宙ステーションのインテリアおよび体験設計を共に手がけるため、マルチディメンショナル体験エージェンシーJourneyとの戦略的パートナーシップを締結したことを発表しました。Journeyは、HiltonおよびAirbusとともに、宇宙飛行士の軌道上での生活と仕事の質を高める宇宙ステーション環境の開発に参画します。 Journeyは、ラスベガスのSphere、ニューヨークのエンパイア・ステート・ビル展望台、プリンセス・クルーズの「サン・プリンセス・ドーム」など、世界的に認知された数々のプロジェクトを手がけてきた豊富な実績を有しています。同エージェンシーは、Starlabプログラムの最初期からの戦略的パートナーであるHiltonと緊密に連携し、Starlabのホスピタリティおよびクルー体験の設計を担当します。Journeyの役割は、機能性と人間性の両方を反映した空間を創造するうえで不可欠な、デザインおよび体験イノベーションの重要な要素を加えることにあります。 「Starlabでは、宇宙飛行士が任務に完全に集中できるよう、直感的で快適な環境を創り出したいと考えています」と、StarlabのCEOであるTim Kopra氏は述べました。「Journe
- 김갑성 기자
- 2025-07-31 05:07
-
저니, 스타랩과 협력해 상업용 우주 정거장 경험 디자인 개발 참여
휴스턴, 2025년 7월 31일 -- 스타랩 스페이스 유한책임회사(Starlab Space LLC)가 차세대 상업용 우주 정거장의 실내 및 경험 디자인을 공동 개발하기 위해 다차원적 경험(MDX) 설계 에이전시인 저니(Journey)와 전략적 파트너십을 체결했다고 발표했다. 저니는 힐튼(Hilton), 에어버스(Airbus)와 함께 우주 비행사들의 생활 및 작업 환경을 혁신적으로 향상시키는 정거장 환경 개발에 참여하게 된다. 저니는 라스베이거스의 스피어(Sphere), 뉴욕시의 엠파이어 스테이트 빌딩 전망대, 프린세스 크루즈의 선 프린세스 돔(Sun Princess Dome) 등 세계적으로 인정받는 프로젝트 포트폴리오를 다수 보유하고 있다. 이 에이전시는 스타랩 프로그램의 초기 전략적 파트너 중 하나인 힐튼과 긴밀히 협력해 스타랩의 호스피탈리티 및 승무원 경험 디자인에 참여하게 된다. 저니의 역할은 디자인 및 경험 혁신이라는 중요한 요소를 추가해 기능과 인류애를 모두 반영하는 공간을 만드는 것이다. 팀 코프라(Tim Kopra) 스타랩 최고경영자(CEO)는 "스타랩을 통해 우주 비행사들이 임무에 완전히 집중할
- 김갑성 기자
- 2025-07-31 05:03
-
Eviva Partners Launches New Think Tank, Exposes Attack on…
NEW YORK, July 31, 2025 -- Eviva Partners, a nonprofit organization dedicated to strengthening public understanding of medical evidence, is proud to announce the launch of Protecting Our Health (POH), a new think tank that brings together international experts in communication, public health and misinformation to confront the rise of pseudoscience. "Medical research has generated a tremendous number of evidence-based interventions, but these are not universally adopted, leading to gaps in care," said Eviva CEO and founder Alex Morozov, a physician-scientist, writer and former
- 김갑성 기자
- 2025-07-31 02:42
-
Egg Medical Announces U.S. Patent and Trademark Office Is…
ST. PAUL, Minn., July 30, 2025 -- In a significant development in an ongoing legal dispute, the U.S. Patent and Trademark Office (USPTO) has issued a final rejection of all claims in U.S. Patent No. 11,660,056 held by Rampart IC, LLC related to a radiation shielding device. The decision follows a request for reexamination by Egg Medical, Inc., which argued that Rampart's '056 patent covered technology that had already been invented—some examples dating as far back as the 1960s. Egg Medical's reexamination request arose out of a lawsuit that Rampart filed in federal cour
- 김갑성 기자
- 2025-07-30 22:24
-
Saronic Unveils Echelon: A Unified Platform for Mission Planni…
AUSTIN, Texas, July 30, 2025 -- Saronic Technologies today unveiled Echelon, a unified platform that enables advanced mission planning, high-fidelity simulation, and real-time command-and-control (C2) for its growing fleet of Autonomous Surface Vessels (ASVs). Built to enable scalable, distributed operations, Echelon allows a single operator to plan, simulate, and execute complex missions across multiple autonomous assets—using a single interface. As maritime environments become increasingly contested and operationally complex, both defense and commercial users require intuitiv
- 김갑성 기자
- 2025-07-30 21:30
-
BON Launches AI-Powered New Drug Research and Develop…
XI'AN, China, July 30, 2025 -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading provider of bio-ingredient solutions for the natural health and personal care industries, today announced the official launch of its AI-driven drug research and development (R&D) business. Leveraging its extensive library of natural compounds - many derived from Traditional Chinese Medicine (TCM) - the Company will apply artificial intelligence algorithms to identify high potential lead compounds, marking a significant evolution in its pharmaceutical strategy.
- 김갑성 기자
- 2025-07-30 21:00
-
Emerald Clinical Trials Confirms CEO Transition and Continuity…
SINGAPORE, July 30, 2025 -- Emerald Clinical Trials, a leading global clinical research organization, today announced a leadership transition. Mary Gunn has stepped down effective immediately. The Board has appointed Glenn Kerkhof, a long-standing Board member and experienced CRO executive, as Interim CEO. The Board has commenced a formal search for a permanent CEO and has asked Glenn Kerkhof to lead the organization through this period to ensure continuity, stability and strong execution. "We thank Mary for her contributions," said Sean Carney, Chair of the Bo
- 김갑성 기자
- 2025-07-30 20:00
-
Dx&Vx Signs USD 220 Million Co-Development and License Agre…
[ 메디채널 김갑성 기자 ] - First global out-licensing deal since founding — tangible return on new drug development investments - Significant milestone payments and future revenue expected — additional out-licensing of proprietary technologies anticipated SEOUL, South Korea, July 30, 2025 -- Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment. On July 30, DXVX announced that it has entered into a co-development and license agreement valued at approximately USD 220 million with a U.S.-based biotech company for its mRNA-based cancer va
- 김갑성 기자
- 2025-07-30 20:00
-
FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2025…
Key Takeaways Participating in the Supplemental Nutrition Assistance Program (SNAP) may help protect against age-related cognitive decline, suggests an analysis of a national study. Compared to non-participants, SNAP participants had a slower decline in cognitive function during the 10-year study period, effectively maintaining an average of two to three additional years of cognitive health. Food insecurity can negatively impact cognitive function, and participating in SNAP may improve participants' diets and nutrition intake. TORONTO, July 30, 2025 -- People w
- 김갑성 기자
- 2025-07-30 19:00
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-10-24_FRI
- Euroclear builds on strong momentum in Q3 2025 16:30
- Light and Moon Together: CHD Celebrates Mid-Autumn Festival Across Southeast Asia 16:03
- Light and Moon Together: CHD Celebrates Mid-Autumn Festival Across Southeast Asia 16:02
- Light and Moon Together: China Huadian Corporation (CHD) Celebrates Mid-Autumn Festival Across Southeast Asia 15:57
- GAC Supplies Official Fleet and 24/7 Support for the 15th National Games in Hong Kong and Macao 15:51
- NTT DOCOMO BUSINESS and NTT Com Asia Launch "APN InterLink" Service in Hong Kong 15:43
- ASEAN-China (Beijing Municipal Administrative Center) Trade and Investment Promotion Conference in Beijing 15:29
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 10월 24일 18시 00분